Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

Clinical trial NCT02050854 · COMPLETED

Trial details

NCT number: NCT02050854
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Bipolar 1 Disorder Schizophrenia Mental Disorder Nervous System Disorders

Start date: 2013-12-01
Primary completion: 2014-01-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.